Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
| ▸ | TTK | P33981 | 1/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4407354 | 0.86 | SYK (0.34) | PAX8L3MBTL1LMNAKMT2AAAK1 | |
| SCHEMBL31709504 | 0.81 | PAX8 (0.37) | PAX8BRD4LMNAKMT2AAAK1 | |
| SCHEMBL3484770 | 0.81 | KMT2A (0.50) | PAX8BRD4LMNAKMT2ATTK | |
| SCHEMBL3301532 | 0.80 | L3MBTL1 (0.34) | L3MBTL1 | |
| SCHEMBL13390733 | 0.79 | GBA1 (0.36) | L3MBTL1AAK1 | |
| SCHEMBL27506246 | 0.79 | PAX8 (0.36) | PAX8BRD4L3MBTL1LMNAKMT2A | |
| SCHEMBL3298954 | 0.78 | L3MBTL1 (0.35) | L3MBTL1 | |
| SCHEMBL4039230 | 0.78 | PAX8 (0.35) | PAX8BRD4 | |
| SCHEMBL10317087 | 0.77 | GBA1 (0.37) | L3MBTL1AAK1 | |
| SCHEMBL13391058 | 0.77 | L3MBTL1 (0.34) | L3MBTL1AAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011052888-A2 | (3-FLUORO-2-HYDROXY)PROPYL-FUNCTIONALIZED ARYL DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENTS FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASES | (주)퓨쳐켐 (KR) | 2011-05-05 | — | — | WO | disclosed |